Gina Calvanese got laid off from Jounce Therapeutics, a struggling Cambridge biotech, in April but landed a higher-paying, six-figure administrative job at a Boston drugmaker within days.
Dwight Morrow was let go by Rubius Therapeutics five months before it shut down in February. But the veteran scientist quickly moved to a small startup and then got a high-ranking job at Moderna, one of the state’s biggest biotechs, all without leaving Cambridge.
Robert Janoschek hasn’t fared as well. He lost his job at Sunovion Pharmaceuticals in Marlborough after its Japanese parent restructured its U.S. subsidiaries. He has applied for hundreds of jobs at other drug companies since April, he said, but can’t find anything he wants.
This article is exclusive to STAT+ subscribers
Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.
Already have an account? Log in
Already have an account? Log in
To submit a correction request, please visit our Contact Us page.
STAT encourages you to share your voice. We welcome your commentary, criticism, and expertise on our subscriber-only platform, STAT+ Connect